Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04876391
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2021-05-04
Brief Title:
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
An Open-label Long-term Extension Trial of Spesolimab Treatment in Adult Patients With Hidradenitis Suppurativa HS
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab Participants who completed treatment can join this study
The purpose of this study is to find out how safe spesolimab is and whether it helps people with hidradenitis suppurativa in the long-term Participants are in this study for about 2 years and 4 months For 2 years participants visit the study site every 2 weeks to get spesolimab injections under the skin At study visits doctors check the severity of participants hidradenitis suppurativa and collect information on any health problems of the participants
The purpose of this study is to find out how safe spesolimab is and whether it helps people with hidradenitis suppurativa in the long-term Participants are in this study for about 2 years and 4 months For 2 years participants visit the study site every 2 weeks to get spesolimab injections under the skin At study visits doctors check the severity of participants hidradenitis suppurativa and collect information on any health problems of the participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2020-005587-55 | EUDRACT_NUMBER | None | None |